ClinicalTrials.gov
ClinicalTrials.gov Menu

Dose Escalation by Boosting Radiation Dose Within the Primary Tumor Using FDG-PET-CT Scan in Stage IB, II and III NSCLC (PET Boost)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01024829
Recruitment Status : Recruiting
First Posted : December 3, 2009
Last Update Posted : January 20, 2017
Sponsor:
Collaborator:
European Union
Information provided by (Responsible Party):
The Netherlands Cancer Institute

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : September 2017
  Estimated Study Completion Date : November 2017